ArticleCancer2026

Timing matters: Impact of covalent BTK inhibitor dose modifications on outcomes in chronic lymphocytic leukemia/small lymphocytic leukemia-A 7-year real-world study.

Jiaojiao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.